Conversely, in streptozotocin (STZ)-induced diabetic mice, Glo1 over-expression prevents diabetes-induced increases in MGO modification of glomerular proteins, increased oxidative stress, and the development of diabetic kidney pathology, despite unchanged levels of diabetic hyperglycemia [106]. This evidence concerns the gene GLO1 and diabetes mellitus.